National Research (NASDAQ:NRC) Share Price Passes Above 200 Day Moving Average – Here’s Why

National Research Corporation (NASDAQ:NRC)’s share price passed above its two hundred day moving average during trading on Friday . The stock has a two hundred day moving average of $17.35 and traded as high as $20.21. National Research shares last traded at $19.53, with a volume of 87,434 shares changing hands.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded National Research from a “sell (d+)” rating to a “hold (c-)” rating in a report on Friday. One analyst has rated the stock with a Hold rating, According to data from MarketBeat, National Research currently has an average rating of “Hold”.

National Research Trading Down 0.7%

The business has a 50-day simple moving average of $17.87 and a two-hundred day simple moving average of $17.35. The stock has a market cap of $444.31 million, a price-to-earnings ratio of 50.08 and a beta of 0.31. The company has a debt-to-equity ratio of 5.48, a current ratio of 0.52 and a quick ratio of 0.52.

National Research (NASDAQ:NRC) last announced its quarterly earnings results on Tuesday, April 28th. The company reported $0.21 earnings per share for the quarter. The firm had revenue of $34.80 million for the quarter. National Research had a return on equity of 122.73% and a net margin of 6.52%.

National Research Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, July 10th. Shareholders of record on Friday, June 26th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a yield of 3.3%. The ex-dividend date of this dividend is Friday, June 26th. National Research’s payout ratio is 164.10%.

Hedge Funds Weigh In On National Research

A number of institutional investors have recently bought and sold shares of NRC. Russell Investments Group Ltd. increased its position in National Research by 85.6% during the third quarter. Russell Investments Group Ltd. now owns 1,997 shares of the company’s stock worth $26,000 after buying an additional 921 shares during the last quarter. EverSource Wealth Advisors LLC increased its position in National Research by 9,535.3% during the second quarter. EverSource Wealth Advisors LLC now owns 1,638 shares of the company’s stock worth $28,000 after buying an additional 1,621 shares during the last quarter. BNP Paribas Financial Markets increased its position in National Research by 85.4% during the third quarter. BNP Paribas Financial Markets now owns 2,496 shares of the company’s stock worth $32,000 after buying an additional 1,150 shares during the last quarter. Strs Ohio acquired a new position in National Research during the first quarter worth approximately $33,000. Finally, Raymond James Financial Inc. acquired a new position in National Research during the second quarter worth approximately $34,000. Institutional investors and hedge funds own 47.26% of the company’s stock.

National Research Company Profile

National Research Corp (NASDAQ: NRC), also known as NRC Health, is a healthcare analytics and performance improvement company specializing in patient and employee experience measurement. The company’s cloud-based platform enables healthcare providers to collect real-time feedback through patient satisfaction surveys, post-discharge outreach, and employee engagement tools. NRC Health integrates clinical, operational and financial data to deliver actionable insights that support quality improvement initiatives and value-based care programs.

Since its founding in the early 1990s and headquartered in Lincoln, Nebraska, National Research has expanded beyond its regional roots to serve more than 1,600 hospitals and 12,000 care sites across the United States and Canada.